Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An agenda for future Social Sciences and Humanities research on energy efficiency: 100 priority research questions.
Foulds C, Royston S, Berker T, Nakopoulou E, Bharucha ZP, Robison R, Abram S, Ančić B, Arapostathis S, Badescu G, Bull R, Cohen J, Dunlop T, Dunphy N, Dupont C, Fischer C, Gram-Hanssen K, Grandclément C, Heiskanen E, Labanca N, Jeliazkova M, Jörgens H, Keller M, Kern F, Lombardi P, Mourik R, Ornetzeder M, Pearson PJG, Rohracher H, Sahakian M, Sari R, Standal K, Živčič L. Foulds C, et al. Humanit Soc Sci Commun. 2022;9(1):223. doi: 10.1057/s41599-022-01243-z. Epub 2022 Jun 30. Humanit Soc Sci Commun. 2022. PMID: 35791377 Free PMC article.
Addressing disparities in European Social Sciences & Humanities research on climate, energy and mobility: insights from a Call for Evidence survey and analysis workshops on the challenges and opportunities of working in Southern and Central & Eastern Europe.
Foulds C, Crowther A, Sorman AH, Cabello V, Bálint D, Tagai G, Varjú V, Robison R, Sánchez EG, Zindulková K. Foulds C, et al. Open Res Eur. 2023 Sep 18;3:150. doi: 10.12688/openreseurope.16237.1. eCollection 2023. Open Res Eur. 2023. PMID: 37969248 Free PMC article.
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.
Chen A, Kim BJ, Mitra A, Vollert CT, Lei JT, Fandino D, Anurag M, Holt MV, Gou X, Pilcher JB, Goetz MP, Northfelt DW, Hilsenbeck SG, Marshall CG, Hyer ML, Papp R, Yin SY, De Angelis C, Schiff R, Fuqua SAW, Ma CX, Foulds CE, Ellis MJ. Chen A, et al. Among authors: foulds ce. Mol Cancer Ther. 2024 Oct 1;23(10):1494-1510. doi: 10.1158/1535-7163.MCT-23-0564. Mol Cancer Ther. 2024. PMID: 38781103 Free PMC article.
A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis.
Chadchan SB, Popli P, Liao Z, Andreas E, Dias M, Wang T, Gunderson SJ, Jimenez PT, Lanza DG, Lanz RB, Foulds CE, Monsivais D, DeMayo FJ, Yalamanchili HK, Jungheim ES, Heaney JD, Lydon JP, Moley KH, O'Malley BW, Kommagani R. Chadchan SB, et al. Among authors: foulds ce. Nat Commun. 2024 Mar 2;15(1):1947. doi: 10.1038/s41467-024-46180-4. Nat Commun. 2024. PMID: 38431630 Free PMC article.
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer.
Gou X, Kim BJ, Anurag M, Lei JT, Young MN, Holt MV, Fandino D, Vollert CT, Singh P, Alzubi MA, Malovannaya A, Dobrolecki LE, Lewis MT, Li S, Foulds CE, Ellis MJ. Gou X, et al. Among authors: foulds ce. Cancer Res. 2023 Oct 2;83(19):3237-3251. doi: 10.1158/0008-5472.CAN-22-3484. Cancer Res. 2023. PMID: 37071495 Free PMC article.
Correction to: Hormonal modulation of ESR1 mutant metastasis.
Gu G, Tian L, Herzog SK, Rechoum Y, Gelsomino L, Gao M, Du L, Kim JA, Dustin D, Lo HC, Beyer AR, Edwards DG, Gonzalez T, Tsimelzon A, Huang HJ, Fernandez NM, Grimm SL, Hilsenbeck SG, Liu D, Xu J, Alaniz A, Li S, Mills GB, Janku F, Kittler R, Zhang XH, Coarfa C, Foulds CE, Symmans WF, Andò S, Fuqua SAW. Gu G, et al. Among authors: foulds ce. Oncogene. 2022 Jan;41(3):460. doi: 10.1038/s41388-021-02104-w. Oncogene. 2022. PMID: 34782721 No abstract available.
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer.
Gou X, Anurag M, Lei JT, Kim BJ, Singh P, Seker S, Fandino D, Han A, Rehman S, Hu J, Korchina V, Doddapaneni H, Dobrolecki LE, Mitsiades N, Lewis MT, Welm AL, Li S, Lee AV, Robinson DR, Foulds CE, Ellis MJ. Gou X, et al. Among authors: foulds ce. Cancer Res. 2021 Dec 15;81(24):6259-6272. doi: 10.1158/0008-5472.CAN-21-1256. Epub 2021 Oct 28. Cancer Res. 2021. PMID: 34711608 Free PMC article.
40 results